efalizumab

Ligand id: 6593

Name: efalizumab

References
1. Jardieu PM, Presta LG. (2004)
Method of treatment using humanized anti-CD11a antibodies.
Patent number: US6703018. Assignee: Genentech, Inc.. Priority date: 27/11/1996. Publication date: 19/03/2004.